Enlivex Therapeutics shares owned by ACT Capital Management
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by ACT Capital Management
from 13F filings
Historical chart of ACT Capital Management investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enlivex Therapeutics by ACT Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-09-30 | $64k | 15k | 4.27 |
| 2022-06-30 | $68k | 15k | 4.53 |
| 2022-03-31 | $140k | 25k | 5.60 |
| 2021-12-31 | $156k | 25k | 6.24 |
| 2021-09-30 | $815k | 83k | 9.88 |
| 2021-06-30 | $735k | 83k | 8.91 |